JP2015503623A5 - - Google Patents

Download PDF

Info

Publication number
JP2015503623A5
JP2015503623A5 JP2014552325A JP2014552325A JP2015503623A5 JP 2015503623 A5 JP2015503623 A5 JP 2015503623A5 JP 2014552325 A JP2014552325 A JP 2014552325A JP 2014552325 A JP2014552325 A JP 2014552325A JP 2015503623 A5 JP2015503623 A5 JP 2015503623A5
Authority
JP
Japan
Prior art keywords
formulation
romidepsin
amount
etoh
mannitol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014552325A
Other languages
English (en)
Japanese (ja)
Other versions
JP6170946B2 (ja
JP2015503623A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/021212 external-priority patent/WO2013106696A1/en
Publication of JP2015503623A publication Critical patent/JP2015503623A/ja
Publication of JP2015503623A5 publication Critical patent/JP2015503623A5/ja
Application granted granted Critical
Publication of JP6170946B2 publication Critical patent/JP6170946B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014552325A 2012-01-12 2013-01-11 ロミデプシン製剤及びその使用 Active JP6170946B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261586066P 2012-01-12 2012-01-12
US61/586,066 2012-01-12
PCT/US2013/021212 WO2013106696A1 (en) 2012-01-12 2013-01-11 Romidepsin formulations and uses thereof

Publications (3)

Publication Number Publication Date
JP2015503623A JP2015503623A (ja) 2015-02-02
JP2015503623A5 true JP2015503623A5 (https=) 2016-03-03
JP6170946B2 JP6170946B2 (ja) 2017-07-26

Family

ID=47604232

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014552325A Active JP6170946B2 (ja) 2012-01-12 2013-01-11 ロミデプシン製剤及びその使用

Country Status (8)

Country Link
US (3) US20130184225A1 (https=)
EP (1) EP2802340B1 (https=)
JP (1) JP6170946B2 (https=)
CN (1) CN104168908A (https=)
AU (1) AU2013201937B8 (https=)
CA (1) CA2863291A1 (https=)
MX (1) MX2014008390A (https=)
WO (1) WO2013106696A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ630311A (en) * 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof
CN106137980B (zh) * 2015-03-31 2021-04-13 深圳翰宇药业股份有限公司 一种罗米地辛脂微球制剂及其制备方法
US10669528B2 (en) 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
EP4049665B1 (en) 2016-03-15 2025-03-12 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
EP3773488A4 (en) * 2018-04-05 2021-11-17 Tarveda Therapeutics, Inc. PHARMACEUTICAL COMPOSITIONS AT REDUCED TERT-BUTANOL LEVELS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8817743D0 (en) * 1988-07-26 1988-09-01 Fujisawa Pharmaceutical Co Fr901228 substance & preparation thereof
JPH0764872A (ja) 1993-08-26 1995-03-10 Fujitsu Ten Ltd データ記憶制御装置
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
EP1582204B1 (en) * 1999-03-03 2013-09-25 Eli Lilly & Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
WO2002020817A1 (en) 2000-09-01 2002-03-14 Fujisawa Pharmaceutical Co., Ltd. A method of producing fr901228
SI2238982T1 (sl) * 2003-06-27 2013-01-31 Astellas Pharma Inc. Terapevtsko sredstvo za mehkotkivni sarkom
GB0511266D0 (en) * 2005-06-02 2005-07-13 Trust Chemical compounds
JP2009539862A (ja) * 2006-06-09 2009-11-19 メリオン リサーチ Ｉｉｉ リミテッド 強化剤を含む固体経口投与剤形
CN101687010A (zh) * 2006-12-29 2010-03-31 格洛斯特制药公司 制备Romidepsin
WO2008127659A2 (en) * 2007-04-13 2008-10-23 University Of Texas Southwestern Medical Center Combination therapy for cancer
JP2010105965A (ja) * 2008-10-30 2010-05-13 Taiyo Yakuhin Kogyo Kk バンコマイシン製剤
RU2607526C2 (ru) * 2009-11-23 2017-01-10 Кьюбист Фармасьютикалз ЭлЭлСи Липопептидные композиции и родственные способы
NZ605526A (en) 2010-07-12 2015-04-24 Celgene Corp Romidepsin solid forms and uses thereof

Similar Documents

Publication Publication Date Title
HRP20210212T1 (hr) Triciklični spoj kao antikancerogeni agensi
JP2015078230A5 (https=)
JP2013014622A5 (https=)
JP2014507446A5 (https=)
JP2015503623A5 (https=)
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
CA2894891A1 (en) Boronic acid derivatives and therapeutic uses thereof
CN107427516B8 (zh) 7-苄基-4-(2-甲基苄基)-2,4,6,7,8,9-六氢咪唑并[1,2-a]吡啶并[3,4-e]嘧啶-5(1h)-酮、其类似物、及其盐、以及它们用于治疗的方法
UA109464C2 (uk) Спірооксіндольні антагоністи mdm2
CY1119433T1 (el) Αμινο-υποκατεστημενες ιμιδαζοπυριδαζινες
JP2014533667A5 (https=)
JP2014129360A5 (https=)
BR112012026289A2 (pt) composto orgânico para uso no tratamento de câncer do fígado
JP2016510019A5 (https=)
JP2016533366A5 (https=)
UY35590A (es) Nuevos compuestos para el tratamiento del cáncer
JP2015500225A5 (https=)
JP2012502037A5 (https=)
BR112016011949A2 (pt) Composto, composição farmacêutica, e, uso dos mesmos”
JP2011105738A5 (https=)
JP2015508103A5 (https=)
JP2017513917A5 (https=)
JP2014218522A5 (https=)
CL2014002386A1 (es) Compuesto inhibidor de cinasa de fosfoinositida 3 en forma anhidra cristalina solida; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento o prevencion de enfermedades tales como epoc, asma, entre otras.
JP2014525449A5 (https=)